Research programme: autoimmune disease vaccines - Innogenetics
Latest Information Update: 27 Nov 2007
Price :
$50 *
At a glance
- Originator Innogenetics
- Class Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 05 Jul 2004 Preclinical trials in Autoimmune disorders in Belgium (unspecified route)